Tenet Healthcare (THC) Stock Sinks As Market Gains: Here's Why

Tuesday, Mar 17, 2026 7:02 pm ET2min read
THC--
Aime RobotAime Summary

- Tenet HealthcareTHC-- (THC) fell 3.49% to $211.64, underperforming the S&P 500's 0.25% gain and lagging its industry's 4.79% decline.

- Analysts forecast Q1 EPS of $4.19 (-3.9% YoY) and $5.39B revenue (+3.15% YoY), with full-year estimates at $17.3/share and $21.99B revenue.

- THCTHC-- holds a Zacks Rank #3 (Hold) despite 1.76% EPS estimate increase, trading at industry-average 12.68 Forward P/E and 1.06 PEG ratio.

Tenet Healthcare (THC) closed the most recent trading day at $211.64, moving -3.49% from the previous trading session. The stock's change was less than the S&P 500's daily gain of 0.25%. Meanwhile, the Dow gained 0.1%, and the Nasdaq, a tech-heavy index, added 0.47%.

Prior to today's trading, shares of the hospital operator had lost 5.11% lagged the Medical sector's loss of 4.79% and the S&P 500's loss of 1.88%.

The investment community will be paying close attention to the earnings performance of Tenet HealthcareTHC-- in its upcoming release. It is anticipated that the company will report an EPS of $4.19, marking a 3.9% fall compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $5.39 billion, reflecting a 3.15% rise from the equivalent quarter last year.

For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $17.3 per share and a revenue of $21.99 billion, representing changes of +3.1% and +3.21%, respectively, from the prior year.

Investors might also notice recent changes to analyst estimates for Tenet Healthcare. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 1.76% higher. Tenet Healthcare is holding a Zacks Rank of #3 (Hold) right now.

In terms of valuation, Tenet Healthcare is currently trading at a Forward P/E ratio of 12.68. This expresses no noticeable deviation compared to the average Forward P/E of 12.68 of its industry.

We can also see that THCTHC-- currently has a PEG ratio of 1.06. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. THC's industry had an average PEG ratio of 1.06 as of yesterday's close.

The Medical - Hospital industry is part of the Medical sector. This group has a Zacks Industry Rank of 56, putting it in the top 23% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.

5 Stocks Set to Double

Each was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They include

Stock #1: A Disruptive Force with Notable Growth and Resilience

Stock #2: Bullish Signs Signaling to Buy the Dip

Stock #3: One of the Most Compelling Investments in the Market

Stock #4: Leader In a Red-Hot Industry Poised for Growth

Stock #5: Modern Omni-Channel Platform Coiled to Spring

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%.

See Our Newest 5 Stocks Set to Double Picks >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report



Tenet Healthcare Corporation (THC): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Zacks is the leading investment research firm focusing on equities earnings estimates and stock analysis for the individual investor, including stock picks, stock screening, portfolio stock tracker and stock screeners. Copyright 2006-2026 Zacks Equity Research, Inc. editor@zacks.com (Manaing editor) webmaster@zacks.com (Webmaster)

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet